Subscribe to Newsletter

19 Japanese companies form Japan Microbiome Consortium (JMBC)

Some of the companies are Ajinomoto, Astellas Pharma, LSI Mediens, Otsuka Pharmaceutical, Ono Pharmaceutical Industry, Kyowa Hakko Kirin, JSR, Shionogi Pharmaceutical, Shiseido, Daiichi Sankyo, Taisho Pharmaceutical, Dainippon Sumitomo, Mitsubishi Tanabe Pharma, DNA chip laboratory, Japan Tobacco Industry, Fuji Rebio, Mitsubishi Chemical, Morishita Junkan, and Urban Innovation Institute, Osaka (secretariat). JMBC will address the analysis of microbial specimens in feces, skin, and oral mucosa of healthy Japanese.

Source: Nikkei Biotech news release, May 24, 2017

Request a quote for deeper information from
contact@asia-tech.eu

© 2018 Window to Japan - Bio 4 Business - Imprint - Terms and Conditions